Welcome to light therapy Guide
Fda Approved Light Therapy Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
Effective Treatments with the Light Therapy Box
from:Light therapy box treatments are used for many things today, not just seasonal affective disorder (SAD)--pregnancy, winter depression, PMS, chronic fatigue, acne, bipolar disorders, sleep disorders, mood disorders, and atopic dermatitis--all beginning with recent studies showing that about 80% of SAD sufferers have high treatment success. Yet research on the light therapy box is still in its infancy stage, with light therapy not 100% accepted by the professional medical field at this time.
Quite a bit has been found out lately about bright light treatments and light therapy research, with the use of the light therapy box a major part in it. The key is the intensity of the light, called the lux, with light therapy box intensity ratings given at a specific distance from the unit as light diminishes with distance. A minimum of 2,500-lux is required for the light therapy box to be effective, but researchers and doctors recommend that a 10,000-lux be used as it is much more powerful, and is considered significantly higher than any standard indoor lighting.
Natural sunlight levels are unpredictable because of the every-changing weather patterns, where a person lives, and the time of year it is. Only on a very bright sunny day can natural sunlight match the 10,000-lux of the light therapy box for their successful treatments. But normally, not every day is sunny and bright on a routine basis, so other options are needed.
To fulfill that need, a variety of the light therapy box products are available to match each person's individual needs. The best light therapy boxes are metal fixtures that contain white fluorescent light bulbs behind a diffuser. The diffuse is important as it provides two purposes: it helps to spread the light evenly over the unit surface, and it absorbs and filters out harmful UV rays.
The light therapy box also needs to be able to be titled slight forward, which allows flexibility of the unit to allow light to be entered into the eye areas of the individual. This tilting also decreases the brightness of the light, creating less glare and helping the individual to be more comfortable during the treatment. Full spectrum lighting needs to have UV rays filtered out for both eye and skin--even though a critical part of the light therapy box is its intensity--with both UV-A and UV-B rays filtered out, producing less glare and more comfort to the individual.
For those who have side effects, even though they are very small and mild, moving away a few inches from the light source and then gradually over a period from two days to two weeks, move back toward the light in increments until the full dose of 10,000-lux is being received. Another method is to reduce the treatment time to 15 minutes instead of 30 minutes per day, gradually moving that time back up a few minutes a day until the desired time exposure is met.
Fda Approved Light Therapy News
Therapy Lasers: Too Good to be True? - VetPracticeNews.com
Therapy Lasers: Too Good to be True? VetPracticeNews.com After years of inferior products and exaggerated claims, we must be specific and accurate with our statements. So this is not a discussion of “light” therapy but “laser” therapy. More specifically, we are talking mainly about high power laser therapy. |
MedX Health Corp. Enters India - One of the World's Largest and Fastest ... - Stockhouse
MedX Health Corp. Enters India - One of the World's Largest and Fastest ... Stockhouse MDX) with worldwide revenues in drug free, non-invasive low level laser light therapy and light imaging systems, announced that their distribution partner in India, HealthX Lasers (www.healthxlasers.com), is working with hospitals, physicians, clinics, ... |
FDA staff backs J&J's Xarelto for heart condition - FierceBiotech
FDA staff backs J&J's Xarelto for heart condition FierceBiotech As Johnson & Johnson ($JNJ) builds the blockbuster pedigree of Xarelto, an FDA reviewer has given the thumbs-up to the new clot-busting drug as a treatment for the heart problem known as acute coronary syndrome. The staffers' recommendation of approval ... |
FDA staff not impressed with Pfizer rare disease drug tafamidis - Pharma Times
FDA staff not impressed with Pfizer rare disease drug tafamidis Pharma Times The chances of Pfizer's tafamidis getting approval in the USA have been hurt after staff at the Food and Drug Administration recommended against giving the green light to the treatment for patients with transthyretin familial amyloid polyneuropathy. |
Viral Genetics' P-IND Clears FDA To Commence Clinical Trials in Humans - MarketWatch (press release)
Viral Genetics' P-IND Clears FDA To Commence Clinical Trials in Humans MarketWatch (press release) The P-IND -- part of a larger, coordinated research effort -- was submitted by the first test site at the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio, which includes patient enrollment at ... |